Nasopharyngeal Swabs Market

Nasopharyngeal Swabs Market (Application: Influenza, COVID-19, Respiratory Syncytial Virus, Bordetella Pertussis Infection, MRSA [Methicillin-resistant Staphylococcus Aureus], and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Nasopharyngeal Swabs Market Outlook 2031

  • The global industry was valued at US$ 267.3 Mn in 2022
  • It is projected to grow at a CAGR of 2.4% from 2023 to 2031 and expected to reach US$ 328.6 Mn by the end of 2031

Analysts’ Viewpoint

Increase in incidence of respiratory infectious diseases is driving the global nasopharyngeal swabs industry. Nasopharyngeal swabs are commonly utilized in diagnostic testing of respiratory diseases, as they are non-invasive and readily available. During the COVID-19 pandemic, increase in diagnosis rate of the disease led to surge in nasopharyngeal swabs market demand. Rise in awareness about the importance of early disease detection is expected to bolster market expansion during the forecast period.

Government bodies across the world implemented initiatives to increase the availability of diagnostic tests, including nasopharyngeal swabs. These initiatives helped to drive demand for the swabs and have led to an increase in investment in the market. Technological advancements in nasopharyngeal swab manufacturing technology offers lucrative opportunities to market players. Companies are focusing on the development of more efficient, accurate, and reliable nasopharyngeal swabs in order to increase revenue.

Nasopharyngeal Swabs Market

Global Nasopharyngeal Swabs Market Introduction

A nasopharyngeal swab is used in clinical diagnostic procedure that entails taking a sample of nasal secretion from the nasopharynx region. This sample is analyzed to identify any organisms or clinical markers that may be responsible for a particular disease. This diagnostic method is commonly used for collecting samples for testing influenza, diphtheria, whooping cough, and other diseases caused by viruses such as MERS and COVID-19.

Nasopharyngeal swabs, also called NP swabs, provide a comprehensive analysis of the sample, allowing healthcare professionals to detect the presence of any organism or rule out potential causes.

According to the Lancet Microbe journal published in January 2023, nasal swab testing can identify previously undetected viruses by checking for the presence of a single immune system molecule, which is not typically included in standard tests.

Rise in Prevalence of Respiratory Infectious Diseases

Respiratory infectious diseases are a group of illness that primarily affect the respiratory system, including the lungs and airways. These are caused by various pathogens, including viruses, bacteria, fungi, and other microorganisms. These diseases can range from mild, self-limiting condition to severe, life threatening infections.

These infections mostly manifest as an acute condition with symptoms that can appear hours or days after the infection, including fever, coughing, sore throats, coryza, shortness of breath, wheezing, and/or breathing difficulties, following fast sociodemographic changes and undoubtedly climatic change.

Respiratory infectious diseases are a significant global health concern, as these lead to substantial morbidity, mortality, and economic impact. According to the World Health Organization (WHO), both in communicable and non-communicable diseases, respiratory infectious diseases rank number one, after heart and encephalic vascular diseases. Lower respiratory tract infections are the third largest cause of death globally; however, in countries with low economic standing, they rank first.

Respiratory infectious diseases pose significant challenges to public health worldwide. Prevention, early detection, and appropriate management are essential in controlling their spread. Increase in cases of respiratory infectious diseases has induced regulatory bodies to initiate early diagnosis program, leading to rise in demand for nasopharyngeal swabs.

Better Collection Efficiency Fueling Demand for Non-woven Swabs

In terms of type, the non-woven swabs segment dominated the global nasopharyngeal swabs market in 2022. The trend is expected to continue during the forecast period. Non-woven nasopharyngeal swabs are designed to be softer and more comfortable for patients during nasopharyngeal sampling process. They are engineered to provide better collection efficiency, ensuring the sample contains an adequate amount of biological material for accurate diagnostic testing and improve the reliability of test results.

COVID-19 Pandemic Increased Demand for Swabs Testing

Based on application, the COVID-19 segment led the global nasopharyngeal swabs market in 2022. The COVID-19 (coronavirus) pandemic increased the demand for nasopharyngeal swabs for testing during the preceding years. Research facilities and labs have stepped up their development-related experiments. Consequently, manufacturers have enhanced their capacity to provide nasopharyngeal swabs that are helpful for viral collection, maintenance, and culture.

Consumption of nasal swabs for COVID-test was high till 2022. The segment is likely to lose market share in the next few years, as the COVID-19 cases are continuously declining. However, the influenza segment is likely to grow at a rapid pace during the forecast period and dominate the market by the end of 2031.

Seasonal influenza an acute respiratory infection caused by influenza viruses due to a range of infections. The influenza A and B viruses spread and produce seasonal outbreaks of sickness during different seasons that prevail in several regions of the world.

According to a report published by WHO, in January 2023, annual epidemics such as seasonal influenza are predicted to cause 3 million to 5 million cases of severe disease and 290,000 to 650,000 respiratory deaths worldwide. Thus, demand for molecular testing to detect influenza viruses that cause severe diseases is continuously increasing, which boosts the usage of nasopharyngeal swabs across the globe.

Large Number of Diagnostic Tests Performed in Hospitals

In terms of end-user, the hospitals segment accounted for the largest global nasopharyngeal swabs market share in 2022. Hospitals are the major hubs for medical diagnostic testing, including respiratory virus testing. With a large number of patients seeking medical care during infectious disease outbreaks, hospitals have a substantial demand for nasopharyngeal swabs to conduct diagnostic tests efficiently.

Nasopharyngeal swabs have become the preferred method for respiratory infectious disease testing among healthcare providers due to their accuracy and reliability.

Regional Analysis

According to nasopharyngeal swabs market report, North America accounted for significant share in 2022. The region has innovative strategies for development of technologically advanced nasopharyngeal swabs. It has a well-developed healthcare infrastructure, which includes advanced diagnostic facilities and well-trained healthcare professionals. This has helped to support the adoption of nasopharyngeal swabs in the region.

As per nasopharyngeal swabs market forecast, Asia Pacific is expected to witness significant industry growth during the forecast period. This is ascribed to large and growing population and high prevalence of respiratory infectious diseases.

According to the Indian Council of Medical Research (ICMR) (March 2023), influenza A subtype H3N2 was the leading cause of growing respiratory illnesses in India. According to ICMR statistics, pan-respiratory virus surveillance has been implemented across 30 VRDLs by ICMR/DHR.

The surveillance results show an increase in the number of influenza A H3N2 cases. H3N2 was shown to have affected around half of all inpatient severe acute respiratory infections (SARI) and outpatient influenza-like diseases. Development of advanced diagnostic facilities, increase in number of trained healthcare professionals, rise in government investment in healthcare infrastructure, and high healthcare spending are driving the nasopharyngeal swabs market size in Asia Pacific.

Analysis of Key Players

Leading companies in the global nasopharyngeal swabs market are Medical Wire & Equipment (MWE), C. R. Bard, Inc. (Becton, Dickinson and Company), Titan Biotech Ltd., Miraclean Technology Co., Ltd., Thermo Fisher Scientific, Inc., Quidel Corporation, COPAN Diagnostics, Inc., YOCON Biology, Trinity Biotech, VIRCELL S.L, and Puritan Medical Products. These companies are increasingly focusing on strategic acquisitions and partnerships to expand product portfolio.

Key Developments in Global Nasopharyngeal Swabs Market

  • In August 2022, a study supported by the NIH on pediatric COVID-19 testing found that school-age children can self-swab. Pediatric self-swabbing will increase testing of school-age populations with less resources.
  • In May 2021, Technimark collaborated with Rhinostics and a P&G subsidiary named iMFLUX for the production, packaging, and distribution of individually packaged medical-grade polypropylene nasal swabs that will assist researchers and healthcare practitioners in identifying and treating possible infections such as COVID-19.
  • In July 2021, researchers from the U.S. Department of Veterans Affairs began conducting studies to evaluate the safety and effectiveness of 3D-printed nasal swabs. The VA is undertaking this initiative to support national healthcare efforts during the pandemic and to address potential shortages of traditional swabs in the commercial supply chain. The agency also aims to provide scientific evidence of the benefits of 3D swabs for non-VA healthcare systems.
  • In May 2021, Shionogi & Co., Ltd. introduced the "LumiraDx SARS-CoV-2 Ag Test" and "LumiraDx Instrument" in Japan as novel coronavirus (SARS-CoV-2) antigen tests. The LumiraDx SARS-CoV-2 Ag test employs samples from a s swab or nasal swab to provide high-sensitivity results comparable to those obtained by PCR while also being quick and efficient.
  • In October 2020, Resolution Medical and Qosina collaborated to provide a 3D-printed sterile nasal swab for COVID-19 testing. The swab is 5.9 inches long and has a soft, lattice-style cage surrounding a flexible helical core that makes it easier for it to fit into the natural channel of the nasal canal.

Each of these players has been profiled in the nasopharyngeal swabs market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Nasopharyngeal Swabs Market Snapshot

Attribute Detail

Size in 2022

US$ 267.3 Mn

Forecast (Value) in 2031

More than US$ 328.6 Mn

Growth Rate (CAGR)

2.4%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Type
    • Foam Tipped Swabs
    • Non-woven Swabs
    • Others
  • Application
    • Influenza
    • COVID-19
    • Respiratory Syncytial Virus
    • Bordetella Pertussis Infection
    • MRSA (Methicillin-resistant Staphylococcus aureus)
    • Others
  • End-user
    • Hospitals
    • Clinics
    • Academia & Research Institutes
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • C. R. Bard, Inc. (Becton, Dickinson and Company)
  • Medical Wire & Equipment (MWE)
  • Titan Biotech Ltd.
  • COPAN Diagnostics, Inc.
  • Miraclean Technology Co., Ltd.
  • Puritan Medical Products
  • YOCON Biology
  • Trinity Biotech
  • VIRCELL S.L
  • Quidel Corporation

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global nasopharyngeal swabs market in 2022?

It was valued at US$ 267.3 Mn in 2022.

How big will be the nasopharyngeal swabs business by 2031?

It is projected to reach US$ 328.6 Mn by 2031.

How will the nasopharyngeal swabs industry grow during the forecast period?

It is anticipated to expand at a CAGR of 2.4% from 2023 to 2031.

Which are the major factors driving demand for nasopharyngeal swabs?

Rise in prevalence of respiratory infectious diseases, increase in awareness about disease diagnosis, and surge in demand for non-invasive and accurate sampling procedures.

Which region will account for major share of the nasopharyngeal swabs sector during the forecast period?

North America is expected to account for the largest share of the market from 2023 to 2031.

Who are the prominent nasopharyngeal swabs players?

Medical Wire & Equipment (MWE), C. R. Bard, Inc. (Becton, Dickinson and Company), Titan Biotech Ltd., Miraclean Technology Co., Ltd., Thermo Fisher Scientific, Inc., Quidel Corporation, COPAN Diagnostics, Inc., YOCON Biology, Trinity Biotech, VIRCELL S.L, Puritan Medical Products.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Nasopharyngeal Swabs Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Nasopharyngeal Swabs Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Industry Events

        5.2. Technological Advancements

        5.3. Epidemiology of Infectious Diseases, by Country/Region

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Type, 2017-2031

            6.3.1. Foam Tipped Swabs

            6.3.2. Non-woven Swabs

            6.3.3. Others

        6.4. Market Attractiveness Analysis, by Type

    7. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017-2031

            7.3.1. Influenza

            7.3.2. COVID-19

            7.3.3. Respiratory Syncytial Virus

            7.3.4. Bordetella Pertussis Infection

            7.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)

            7.3.6. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Nasopharyngeal Swabs Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017-2031

            8.3.1. Hospitals

            8.3.2. Clinics

            8.3.3. Academia & Research Institutes

            8.3.4. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017-2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Nasopharyngeal Swabs Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Type, 2017-2031

            10.2.1. Foam Tipped Swabs

            10.2.2. Non-woven Swabs

            10.2.3. Others

        10.3. Market Value Forecast, by Application, 2017-2031

            10.3.1. Influenza

            10.3.2. COVID-19

            10.3.3. Respiratory Syncytial Virus

            10.3.4. Bordetella Pertussis Infection

            10.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)

            10.3.6. Others

        10.4. Market Value Forecast, by End-user, 2017-2031

            10.4.1. Hospitals

            10.4.2. Clinics

            10.4.3. Academia & Research Institutes

            10.4.4. Others

        10.5. Market Value Forecast, by Country, 2017-2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Nasopharyngeal Swabs Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017-2031

            11.2.1. Foam Tipped Swabs

            11.2.2. Non-woven Swabs

            11.2.3. Others

        11.3. Market Value Forecast, by Application, 2017-2031

            11.3.1. Influenza

            11.3.2. COVID-19

            11.3.3. Respiratory Syncytial Virus

            11.3.4. Bordetella Pertussis Infection

            11.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)

            11.3.6. Others

        11.4. Market Value Forecast, by End-user, 2017-2031

            11.4.1. Hospitals

            11.4.2. Clinics

            11.4.3. Academia & Research Institutes

            11.4.4. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Nasopharyngeal Swabs Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017-2031

            12.2.1. Foam Tipped Swabs

            12.2.2. Non-woven Swabs

            12.2.3. Others

        12.3. Market Value Forecast, by Application, 2017-2031

            12.3.1. Influenza

            12.3.2. COVID-19

            12.3.3. Respiratory Syncytial Virus

            12.3.4. Bordetella Pertussis Infection

            12.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)

            12.3.6. Others

        12.4. Market Value Forecast, by End-user, 2017-2031

            12.4.1. Hospitals

            12.4.2. Clinics

            12.4.3. Academia & Research Institutes

            12.4.4. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Nasopharyngeal Swabs Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type, 2017-2031

            13.2.1. Foam Tipped Swabs

            13.2.2. Non-woven Swabs

            13.2.3. Others

        13.3. Market Value Forecast, by Application, 2017-2031

            13.3.1. Influenza

            13.3.2. COVID-19

            13.3.3. Respiratory Syncytial Virus

            13.3.4. Bordetella Pertussis Infection

            13.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)

            13.3.6. Others

        13.4. Market Value Forecast, by End-user, 2017-2031

            13.4.1. Hospitals

            13.4.2. Clinics

            13.4.3. Academia & Research Institutes

            13.4.4. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Nasopharyngeal Swabs Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Type, 2017-2031

            14.2.1. Foam Tipped Swabs

            14.2.2. Non-woven Swabs

            14.2.3. Others

        14.3. Market Value Forecast, by Application, 2017-2031

            14.3.1. Influenza

            14.3.2. COVID-19

            14.3.3. Respiratory Syncytial Virus

            14.3.4. Bordetella Pertussis Infection

            14.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)

            14.3.6. Others

        14.4. Market Value Forecast, by End-user, 2017-2031

            14.4.1. Hospitals

            14.4.2. Clinics

            14.4.3. Academia & Research Institutes

            14.4.4. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2022

        15.3. Company Profiles

            15.3.1. Thermo Fisher Scientific, Inc.

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company)

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Medical Wire & Equipment (MWE)

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Titan Biotech Ltd.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. COPAN Diagnostics, Inc.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

                15.3.5.5. Strategic Overview

            15.3.6. Miraclean Technology Co., Ltd.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

                15.3.6.5. Strategic Overview

            15.3.7. Puritan Medical Products

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

                15.3.7.5. Strategic Overview

            15.3.8. YOCON Biology

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

                15.3.8.5. Strategic Overview

            15.3.9. Trinity Biotech

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

                15.3.9.5. Strategic Overview

            15.3.10. VIRCELL S.L.

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Product Portfolio

                15.3.10.3. Financial Overview

                15.3.10.4. SWOT Analysis

                15.3.10.5. Strategic Overview

            15.3.11. Quidel Corporation

                15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Product Portfolio

                15.3.11.3. Financial Overview

                15.3.11.4. SWOT Analysis

                15.3.11.5. Strategic Overview

    List of Tables

    Table 1: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 2: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 3: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 4: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 5: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 6: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 7: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 8: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 9: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 10: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 11: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 12: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 13: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 14: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 15: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 16: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 17: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 18: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 19: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 20: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 21: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 22: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 23: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 24: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

    List of Figures

    Figure 01: Global Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031

    Figure 02: Global Nasopharyngeal Swabs Market Value Share, by Type, 2022

    Figure 03: Global Nasopharyngeal Swabs Market Value Share, by Application, 2022

    Figure 04: Global Nasopharyngeal Swabs Market Value Share, by End-user, 2022

    Figure 05: Global Nasopharyngeal Swabs Market Value Share Analysis, by Type, 2022 and 2031

    Figure 06: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Foam Tipped Swabs, 2017-2031

    Figure 07: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Non-woven Swabs, 2017-2031

    Figure 08: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031

    Figure 09: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Type, 2023-2031

    Figure 10: Global Nasopharyngeal Swabs Market Value Share Analysis, by Application, 2022 and 2031

    Figure 11: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Influenza, 2017-2031

    Figure 12: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by COVID-19, 2017-2031

    Figure 13: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Respiratory Syncytial Virus, 2017-2031

    Figure 14: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Bordetella Pertussis Infection, 2017-2031

    Figure 15: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by MRSA (Methicillin-Resistant Staphylococcus aureus), 2017-2031

    Figure 16: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031

    Figure 17: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Application, 2023-2031

    Figure 18: Global Nasopharyngeal Swabs Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 19: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Hospitals, 2017-2031

    Figure 20: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Clinics 2017-2032

    Figure 21: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031

    Figure 22: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Academia & Research Institutes

    Figure 23: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031

    Figure 24: Global Nasopharyngeal Swabs Market Value Share Analysis, by Region 2022 and 2031

    Figure 25: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Region 2023-2031

    Figure 26: North America Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031

    Figure 27: North America Nasopharyngeal Swabs Market Value Share Analysis, by Country 2022 and 2031

    Figure 28: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Country 2023-2031

    Figure 29: North America Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031

    Figure 30: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031

    Figure 31: North America Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031

    Figure 32: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031

    Figure 33: North America Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031

    Figure 34: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031

    Figure 35: Europe Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031

    Figure 36: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 37: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 38: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031

    Figure 39: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031

    Figure 40: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031

    Figure 41: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031

    Figure 42: Europe Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031

    Figure 43: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031

    Figure 44: Asia Pacific Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031

    Figure 45: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 46: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 47: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031

    Figure 48: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031

    Figure 49: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031

    Figure 50: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031

    Figure 51: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031

    Figure 52: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031

    Figure 53: Latin America Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031

    Figure 54: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 55: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 56: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031

    Figure 57: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031

    Figure 58: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031

    Figure 59: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031

    Figure 60: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031

    Figure 61: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031

    Figure 62: Middle East and Africa Nasopharyngeal Swabs Market Value (US$ Mn), 2017-2031

    Figure 63: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 64: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Country/Sub-region, 2023-2031

    Figure 65: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031

    Figure 66: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Type 2023-2031

    Figure 67: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031

    Figure 68: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Application 2023-2031

    Figure 69: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031

    Figure 70: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness by End-user 2023-2031

    Figure 71: Company Share Analysis Nasopharyngeal Swabs, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved